- Investing Ideas
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
14
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
14 companies
CorMedix
Market Cap: US$572.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.10
7D
-4.2%
1Y
-41.2%
Incyte
Market Cap: US$24.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$120.77
7D
0.8%
1Y
40.7%
Protalix BioTherapeutics
Market Cap: US$195.8m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.62
7D
7.4%
1Y
62.7%
ACADIA Pharmaceuticals
Market Cap: US$5.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$29.45
7D
2.3%
1Y
17.2%
Exelixis
Market Cap: US$12.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$50.38
7D
-11.1%
1Y
30.9%
CareDx
Market Cap: US$2.4b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$47.31
7D
4.0%
1Y
290.0%
Eli Lilly
Market Cap: US$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,220.28
7D
4.3%
1Y
84.8%
Earth Science Tech
Market Cap: US$30.1m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.099
7D
6.5%
1Y
-51.7%
Sotera Health
Market Cap: US$5.5b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.89
7D
5.1%
1Y
20.2%
Rigel Pharmaceuticals
Market Cap: US$784.9m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$41.87
7D
3.4%
1Y
14.5%
Aurinia Pharmaceuticals
Market Cap: US$2.0b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$15.45
7D
1.7%
1Y
28.6%
TG Therapeutics
Market Cap: US$7.1b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$49.50
7D
-0.8%
1Y
77.6%
Medpace Holdings
Market Cap: US$16.9b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$596.98
7D
1.6%
1Y
27.6%
CapForce
Market Cap: US$68.4m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$4.60
7D
-8.0%
1Y
4,599,900.0%